BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 2007
View Archived Issues
Mucosal trivalent vaccine against botulism toxin identified at DOR BioPharma
Read More
Novel agents for metabolic disorders described in recent patents
Read More
Recent patents describe new compounds targeting cardiovascular diseases
Read More
New agents for treating disorders of hemostasis reported in recent patents
Read More
HyCAMP shows greater efficacy than Camptosar in metastatic colorectal cancer
Read More
New safety data presented on Riquent
Read More
ANAVEX 1-41 and ANAVEX 2-73 show potential in preclinical Alzheimer's studies
Read More
CuraGen completes sale of 454 Life Sciences to Roche
Read More
Genzyme to acquire Bioenvision
Read More
Ranbaxy acquires 13 derma products from BMS
Read More
New phase II trial for Panzem NCD with Temodar in recurrent GBM
Read More
Fx-1006A studied for familial amyloid polyneuropathy in phase II/III study
Read More
Talima Therapeutics closes new Series B funding round
Read More
Avexa receives grant to develop new generation of HIV antiviral drugs
Read More
Primary endpoint met in pivotal study of aztreonam lysine in cystic fibrosis
Read More
Takeda licenses BioWa's Potelligent technology for antibody development
Read More
Clinical utility, tolerability of desvenlafaxine demonstrated in major depression patients
Read More
Durable fibromyalgia responses seen with pregabalin
Read More
Clinical trials in urological diseases
Read More
Preclinical data on new drugs for pulmonary inflammatory diseases
Read More
Archexin cleared to begin phase II trial in renal cell carcinoma
Read More
New European trial studies Vascular Wrap
Read More
Protherics withdraws European application for Voraxaze
Read More
Torisel approved for advanced renal cell carcinoma
Read More
Telavancin begins European review for cSSTI
Read More
